NCT06527495 Clinical Pharmacogenetic Study of Sorafenib in Egyptian Patients With Hepatocellular Carcinoma Status RECRUITING Phase PHASE1/PHASE2
NCT06526338 Adjuvant IP-001 Treatment for HCC Patients Following Surgical Resection and Ablation or Ablation Alone Status RECRUITING Phase PHASE2
NCT06526104 Study of Tremelimumab and Durvalumab (MEDI4736) (T300+D) in Advanced Hepatocellular Carcinomas With Child-Pugh-B Cirrhosis Status RECRUITING Phase PHASE2
NCT06523608 Prediction of Decompensation and HCC Development in Advanced Chronic Liver Disease Status RECRUITING Phase N/A
NCT06519721 Safety and Efficacy Study of Lenvatinib Combined With VIC-1911 for the Treatment of Advanced HCC Status ACTIVE_NOT_RECRUITING Phase NA
NCT06519578 Prospective Real-World Study of HAIC With Raltitrexed or 5-Fluorouracil for the Treatment of Hepatocellular Carcinoma Status RECRUITING Phase NA
NCT06518434 A Pilot Study on the Effect of Cannabis Oil in Untreatable Liver Cancer Patients Status RECRUITING Phase PHASE2
NCT06512467 Donafenib Combine With Sintilimab and HAIC in Neoadjuvant of Resectable Hepatocellular Carcinoma Status NOT_YET_RECRUITING Phase PHASE2
NCT06508307 A Phase I Clinical Study of Intratumoral Injection Oncolytic Vaccinia Virus GC001 in Patient With Advanced Solid Tumors Status RECRUITING Phase PHASE1
NCT06503146 18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection Status RECRUITING Phase PHASE2
NCT06498622 Adjuvant Treatment of Patients With High Risk of Recurrent Hepatocellular Carcinoma With Donafenib in Combination With Envafolimab Status RECRUITING Phase PHASE2
NCT06496113 Robotic Versus Laparoscopic Liver Resection for Hepatocellular Carcinoma Status COMPLETED Phase N/A
NCT06482008 HAIC Combined With Adebrelimab Plus Apatinib as the First-line Treatment for HCC in BCLC Stage C: An Open-label, Single-arm, Phase II Study Status NOT_YET_RECRUITING Phase PHASE2
NCT06478927 Backline Treatment of Advanced Hepatocellular Carcinoma With Palbociclib Status RECRUITING Phase NA
NCT06478719 To Evaluate Safety and Efficacy of FB-1603 in Hepatocellular Carcinoma Patient Receiving Transarterial Chemoembolization Status RECRUITING Phase PHASE1/PHASE2
NCT06478693 A Study of MT-303 in Adults With Advanced or Metastatic GPC3-Expressing Cancers, Including HCC Status RECRUITING Phase PHASE1
NCT06475287 HAIC Combined With TQB2450 and Anlotinib in Second-line Treatment of Advanced Hepatocellular Carcinoma Status NOT_YET_RECRUITING Phase PHASE2
NCT06475118 Comparison of Serum Myokine Dosages and Imaging Methods in the Evaluation of Sarcopenia in Patients With Hepatocellular Carcinoma Status RECRUITING Phase NA
NCT06467799 Neoadjuvant HAIC and PD-1 Plus Adjuvant PD-1 for High-risk Recurrent HCC Status RECRUITING Phase PHASE2